南通泰禾化工股份有限公司 证券代码：301665 证券简称：泰禾股份 公告编号：2025-016 二、募集资金投资项目情况 根据《南通泰禾化工股份有限公司首次公开发行股票并在创业板上市招股说 明书》中披露的拟投入募集资金金额。为保证募投项目的顺利实施和募集资金的 高效使用，公司根据实际募集资金情况，对本次募集资金项目拟投入金额进行调 整，募集资金不足部分由公司以自有资金等方式解决，具体情况如下： | 项目名称 | 实施主体 | 总投资 | 调整前拟 使用募集 资金投资 | 调整后拟使 用募集资金 | | --- | --- | --- | --- | --- | | | | | | 投资金额 | | | | | 金额 | | | 杀菌剂项目 | | 100,472.26 | 89,610.72 | 26,827.28 | | 其中：嘧菌酯原药项目 | 泰禾股份 | 22,940.00 | 21,000.73 | 18,027.28 | | 嘧菌酯中间体项目 | 泰禾股份 | 27,652.26 | 26,362.07 | - | | 丙硫菌唑、肟菌酯原药项目 | 江西天宇 | 10,900.00 | 8,89 ...

证券代码：301665 证券简称：泰禾股份 公告编号：2025-019 南通泰禾化工股份有限公司 关于购买董监高责任险的公告 二、 审议程序 南通泰禾化工股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召开第 三届董事会第十七次会议、第三届监事会第十一次会议，审议《关于购买董监高 责任险的议案》，为进一步完善公司风险管理体系，促进公司董事、监事及高级 管理人员在其职责范围内充分行使职权、履行职责，降低公司运营风险，保障广 大投资者利益，根据《上市公司治理准则》等有关规定，公司拟为公司及公司全 体董事、监事、高级管理人员购买责任保险（以下简称"董监高责任险"）。公司全 体董事、监事均回避表决，该议案直接提交公司 2024 年年度股东会审议。现将 有关事宜公告如下： 一、责任保险方案 1、投保人：南通泰禾化工股份有限公司 2、被保险人：公司及全体董事、监事、高级管理人员（具体以最终签订的保险 合同为准） 3、赔偿限额：累计赔偿限额不超过人民币 3,000 万元/年（具体以最终签订的保 险合同为准） 4、保险费：不超过人民币 20 万元/年（具体以保险公司最终报价审批数据为准） 5、保险期限：保险 ...

南通泰禾化工股份有限公司 2024 年度财务决算报告 2024 年，在公司董事会的领导下，通过公司全体员工的不懈努力，公司在积 极防范经营风险的同时，采取各种有效措施，保持了公司经营业绩持续稳定快速 增长，现将公司 2024 年度的决算情况报告如下： 一、主要财务数据 单位：元 | 项目 | 2024 年 | 2023 年 | 同比变动 | | --- | --- | --- | --- | | 营业收入 | 4,236,282,345.30 | 3,868,331,534.94 | 9.51% | | 归属于母公司所有者的净利润 | 265,939,065.46 | 346,475,139.00 | -23.24% | | 经营活动产生的现金流量净额 | -68,506,167.99 | 632,950,983.18 | -110.82% | | 净资产收益率（%） | 9.21 | 13.45 | -4.24 | | 总资产 | 5,588,250,011.74 | 4,773,886,638.27 | 17.06% | | 负债总额 | 2,124,759,531.67 | 1,609,017,777. ...

证券代码：301665 证券简称：泰禾股份 公告编号：2025-011 南通泰禾化工股份有限公司 关于召开 2024 年年度股东会的通知 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 南通泰禾化工股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召开了 第三届董事会第十七次会议，公司董事会决定于 2025 年 5 月 21 日以现场投票与 网络投票相结合的方式召开公司 2024 年年度股东会（以下简称"本次会议"或"本 次股东会"），现将会议的有关情况通知如下： 一、本次股东会召开的基本情况 1、股东会届次：2024 年年度股东会 2、股东会的召集人：公司董事会 3、会议召开的合法、合规性：本次股东会的召集、召开符合有关法律、行 政法规、部门规章、其他规范性文件及《公司章程》的有关规定。 4、会议召开的日期与时间 （1）现场会议召开时间：2025 年 5 月 21 日（星期三）15:00 （2）网络投票时间：2025 年 5 月 21 日 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 5 月 21 日 9:15-9:25， ...

证券代码：301665 证券简称：泰禾股份 公告编号：2025-002 南通泰禾化工股份有限公司 第三届监事会第十一次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 南通泰禾化工股份有限公司（以下简称"公司"）第三届监事会第十一次会议 通知已于 2025 年 4 月 14 日通过书面方式送达。会议于 2025 年 4 月 24 日以现 场结合通讯的表决方式在公司会议室召开。本次会议应出席监事 3 名，实际出席 监事 3 名（其中通讯出席 1 人）。会议由监事会主席李正先先生召集并主持。本 次会议的召开符合《中华人民共和国公司法》等法律、法规、规范性文件和《公 司章程》的有关规定，会议合法、有效。 二、监事会会议审议情况 全体监事经过认真审议和表决，形成如下决议： 1、审议通过《关于公司 2024 年年度报告及其摘要的议案》 经审核，监事会认为：公司董事会对《2024 年年度报告及其摘要》的编制和 审议程序符合法律、法规和《公司章程》的有关规定，其内容与格式符合中国证 监会和深圳证券交易所的各项规定，所包含的信息真实、准确、 ...

证券代码：301665 证券简称：泰禾股份 公告编号：2025-001 南通泰禾化工股份有限公司 第三届董事会第十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 南通泰禾化工股份有限公司（以下简称"公司"）第三届董事会第十七次会议 通知已于 2025 年 4 月 14 日通过书面方式送达。会议于 2025 年 4 月 24 日以现 场结合通讯方式在公司会议室召开。本次会议应出席董事 9 名，实际出席董事 9 名（其中通讯方式出席董事 5 名）。会议由董事长田晓宏先生召集并主持，公司 监事列席了会议。本次会议的召开和表决程序符合《中华人民共和国公司法》等 法律、法规、规范性文件和《公司章程》的有关规定，会议合法、有效。 二、董事会会议审议情况 全体董事经过认真审议和表决，形成如下决议： 1、审议通过了《关于公司 2024 年年度报告及其摘要的议案》 公司董事会严格按照《证券法》及《深圳证券交易所创业板股票上市规则》 等规定，并根据公司自身实际情况，完成了 2024 年年度报告全文及其摘要的编 制及审议工作，公司董事、监事 ...

根据中汇会计师事务所（特殊普通合伙）出具的标准无保留意见的审计报告， 公司 2024 年度实现合并报表归属于上市公司股东的净利润 265,939,065.46 元， 其中，母公司实现净利润为 105,276,152.51 元。根据《公司法》和《公司章程》 的有关规定，提取法定盈余公积金 10,527,615.25 元，计提任意盈余公积金 5,263,807.63 元。截至 2024 年 12 月 31 日，合并报表可供分配利润为 2,155,039,049.07 元，母公司报表可供分配利润 690,169,263.82 元。按照合并报表、 母公司报表中可供分配利润孰低的原则，本期可供分配的利润以母公司报表期末 未分配利润为依据。 证券代码：301665 证券简称：泰禾股份 公告编号：2025-012 南通泰禾化工股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 南通泰禾化工股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召开第 三届董事会第十七次会议、第三届监事会第十一次会议，审议通过了《关 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 南通泰禾化工股份有限公司（以下简称"公司"）于2025年4月24日召开第三 届董事会第十七次会议及第三届监事会第十一次会议，审议通过了《关于提请 股东会授权董事会制定并实施中期分红方案的议案》，为维护公司价值及股东 权益，进一步提高分红频次，增强投资者回报水平，根据《公司法》《上市公 司监管指引第3号——上市公司现金分红》、深圳证券交易所《上市公司自律 监管指引第2号——创业板上市公司规范运作》等法律法规、规范性文件及《 公司章程》等相关规定，在确保公司持续稳健经营及长远发展的前提下，公司 拟通过增加分红频次方式进一步增强投资者获得感。为进一步简化中期分红程 序，公司董事会提请股东会授权董事会在授权范围内制定并实施2025年度中期 分红方案。现将具体内容公告如下： 证券代码：301665 证券简称：泰禾股份 公告编号：2025-013 南通泰禾化工股份有限公司 关于提请股东会授权董事会制定并实施 中期分红方案的公告 2、在董事会审议通过2025年度中期分红方案后，公司将在法定期限内择 期完成分红事项； 3、办理其 ...

Financial Performance - The company's operating revenue for 2024 was CNY 4,236,282,345.30, representing a 9.51% increase compared to CNY 3,868,331,534.94 in 2023[5]. - The net profit attributable to shareholders for 2024 decreased by 23.24% to CNY 265,939,065.46 from CNY 346,475,139.00 in 2023[5]. - The net cash flow from operating activities for 2024 was negative CNY 68,506,167.99, a decline of 110.82% compared to CNY 632,950,983.18 in 2023[5]. - The total assets at the end of 2024 increased by 17.06% to CNY 5,588,250,011.74 from CNY 4,773,886,638.27 at the end of 2023[5]. - The company's gross profit margin for pesticides decreased by 2.62% to 18.75%, despite a revenue increase of 11.40%[76]. - The total revenue for 2024 reached ¥4,236,282,345.30, representing a year-on-year increase of 9.51% compared to ¥3,868,331,534.94 in 2023[74]. Dividend Distribution - The company plans to distribute a cash dividend of 4 RMB per 10 shares to all shareholders, based on a total of 450,000,000 shares[5]. - The total distributable profit for the period is 690,169,263.82 yuan, with the cash dividend accounting for 100% of the total profit distribution[172]. - The cash dividend distribution plan is consistent with the company's articles of association and dividend management measures[172]. Market Conditions - The global pesticide industry is expected to shrink by 6.3% in 2024, with a market value of USD 70.061 billion, reflecting a challenging economic environment[30]. - The company is facing challenges due to overcapacity in the pesticide market, leading to price declines and reduced profit margins[31]. - The pesticide industry is facing multiple pressures including policy-driven transformation, market saturation, and accelerated technological iteration, necessitating mergers, upgrades, and expansions among manufacturers[32]. - The global pesticide market is projected to grow due to increasing world population, with the UN forecasting a rise to 8.2 billion by mid-2024 and 10.3 billion in the next 60 years, driving long-term demand for pesticide products[34]. Product Development and Innovation - The company has developed a continuous production technology for the fungicide "Bacillus subtilis," achieving a product quality of over 99%[45]. - The company has successfully developed new catalysts for the production of methoxypropyl acrylate fungicides, enhancing efficiency and reducing production costs[45]. - The company is focusing on developing new formulations, as seen with products like "草铵·草甘膦可溶液剂" at 36% concentration[47]. - The company has established a professional team for new pesticide creation, equipped with advanced laboratories and testing facilities[52]. Environmental Management - The company strictly adheres to environmental protection laws and regulations, ensuring compliance with pollutant discharge standards for various emissions[185]. - The company has implemented a strict pollutant discharge management system, ensuring compliance with environmental regulations and timely payment of environmental taxes[182]. - The company has achieved compliance in all major pollutant discharges, with no exceedances reported in the latest assessments[184]. - The company has invested a total of 53.62 million yuan in environmental governance and protection in 2024, focusing on self-monitoring, operation of environmental facilities, and compliance disposal of hazardous waste[191]. Governance and Management - The company maintains independence in assets, personnel, finance, institutions, and business operations, ensuring no significant overlap with controlling shareholders[127]. - The company has a robust governance structure in place, complying with relevant laws and regulations, and has established internal control systems[125]. - The management team includes professionals with extensive experience in their respective fields, enhancing the company's operational capabilities[139][140][141]. - The company has established a salary management system as the basis for salary and bonus distribution[162]. Employee Management - The total number of employees at the end of the reporting period is 2,467, with 751 in the parent company and 1,716 in major subsidiaries[161]. - The company promotes a learning culture and plans targeted training programs for employees in 2024[168]. - Employee income consists of basic salary, performance salary, allowances, bonuses, and various benefits[163]. - The company actively promotes resource utilization and circular economy practices to support sustainable development[198]. Risk Management - The company faces geopolitical risks due to its high export business, which may impact operations and financial performance; it plans to improve compliance management and risk identification mechanisms[112]. - The company is addressing climate risks by accelerating the development of a product matrix that responds to extreme weather conditions affecting crop protection needs[113]. - The company is implementing measures to mitigate exchange rate risks, including studying international trade policies and using financial tools to lock in exchange rates[114]. - The company recognizes intensified industry competition and plans to leverage its strengths in R&D, high-end manufacturing, and global market layout to maintain sustainable growth[115].

Financial Performance - The company's revenue for Q1 2025 reached ¥1,032,507,477.20, representing an 18.50% increase compared to ¥871,289,579.19 in the same period last year[5]. - Net profit attributable to shareholders was ¥78,531,353.80, a significant increase of 50.94% from ¥52,029,058.53 year-on-year[5]. - The net profit after deducting non-recurring gains and losses was ¥75,447,293.68, up 59.79% from ¥47,215,195.37 in the previous year[5]. - Total operating revenue for the current period reached ¥1,032,507,477.20, an increase of 18.5% compared to ¥871,289,579.19 in the previous period[19]. - Net profit for the current period reached ¥110,869,847.07, a significant increase from ¥50,928,357.53 in the previous period, representing a growth of approximately 117.5%[20]. - Operating profit rose to ¥132,686,367.57, compared to ¥56,440,530.14 in the prior period, marking an increase of about 134%[20]. - Basic and diluted earnings per share both improved to ¥0.19, up from ¥0.13 in the previous period, reflecting a growth of 46.2%[21]. - Total comprehensive income for the current period was ¥114,131,053.10, compared to ¥52,355,311.99 in the previous period, indicating an increase of approximately 117.5%[20]. - The company reported a total revenue from sales of goods and services amounting to ¥892,332,685.71, compared to ¥637,666,675.04 in the previous period, an increase of approximately 40%[21]. Assets and Liabilities - The company's total assets increased by 4.46% to ¥5,837,702,882.91 from ¥5,588,250,011.74 at the end of the previous year[5]. - Total assets reached ¥5,837,702,882.91, compared to ¥5,588,250,011.74, marking an increase of 4.5%[16]. - Total liabilities increased to ¥2,263,342,555.77 from ¥2,124,759,531.67, reflecting a rise of 6.5%[16]. - The company's retained earnings grew to ¥2,233,570,402.87, up from ¥2,155,039,049.07, an increase of 3.6%[17]. - Non-current assets totaled ¥3,381,517,436.55, slightly up from ¥3,352,186,770.72, indicating a growth of 0.9%[16]. Cash Flow - Cash flow from operating activities showed a slight decline, with a net outflow of ¥69,996,865.00 compared to ¥68,992,328.51 in the same period last year, a change of -1.46%[5]. - Cash and cash equivalents decreased to ¥455,209,925.97 from ¥503,804,287.23, a decline of 9.6%[15]. - Cash and cash equivalents at the end of the period totaled ¥453,172,051.04, up from ¥297,631,491.35 at the end of the previous period, representing a growth of about 52.3%[22]. - Investment activities resulted in a net cash outflow of ¥167,032,489.81, slightly improved from the previous period's outflow of ¥170,371,057.70[22]. - Financing activities generated a net cash inflow of ¥188,737,875.06, compared to ¥129,038,181.57 in the previous period, reflecting an increase of about 46.3%[22]. Operational Metrics - The company's cash flow from financing activities showed a 46.27% increase, totaling ¥188,737,875.06 compared to ¥129,038,181.57 in the previous year[10]. - Sales expenses surged by 104.26% to ¥31,192,020.35, primarily due to increased salaries and promotional costs[10]. - Inventory levels rose significantly by 34.79% to ¥711,325,981.71, driven by strong demand and increased stocking[10]. - Accounts receivable increased to ¥1,063,273,484.55, up 6.4% from ¥999,756,907.83[15]. - Total operating costs amounted to ¥900,080,013.45, up from ¥809,495,999.93, reflecting a growth of 11.3%[19]. - The weighted average return on equity improved to 2.56%, up from 1.87% in the same period last year[5]. - The company has maintained a stable operational status with increased market sales contributing to revenue and profit growth[9].